Literature DB >> 11873624

[Clinical and serological characteristics of systemic lupus erythematosus: 128 cases].

I Ghedira1, W Sakly, M Jeddi.   

Abstract

OBJECTIVE: To analyse the clinical and serological characteristics of systemic lupus erythematosus (SLE) in the center of Tunisia.
METHODS: We studied 128 patients with SLE aged one to 73 years. Antinuclear antibodies (ANA) were detected by an immunofluorescence method. Anti-double-stranded DNA (anti-dsDNA) antibodies, anti-extractable nuclear antigen antibodies (anti-Sm, anti-SS-A, anti-SS-B and anti-RNP) and anti-cardiolipin (aCL of IgG, IgA and IgM isotypes) antibodies were detected by ELISA.
RESULTS: Malar rash (71%) and anemia (71%) were the most common clinical manifestations. Arthritis was seen in 62.5%. Severe kidney damage was observed in 39%. Pericarditis and pleuritis were observed in only 23%. Neurological manifestations (16%) were uncommon. Clinical manifestations of anti-phospholipid syndrome (SAPL) were observed in 15%. ANA were detected in 100%, anti-dsDNA in 76%, anti-Sm in 55.5%, anti-SS-A in 64%, anti-SS-B in 33.6%, anti-RNP in 49%. aCL of IgG, IgA and IgM isotypes were detected in 63.5%, 49% and 40.6% of the patients respectively. The only significant positive clinical associations were those of arthritis with anti-dsDNA antibodies (p = 0.022) and malar rash with anti-SS-A antibodies (p = 0.002).
CONCLUSIONS: This study suggests that tunisians with SLE present, in general, a mild form of disease predominantly manifested by cutaneous, musculoskeletal and hematologic involvement but low prevalence of major organ damage.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11873624     DOI: 10.1016/s0369-8114(01)00262-0

Source DB:  PubMed          Journal:  Pathol Biol (Paris)        ISSN: 0369-8114


  6 in total

1.  Type 1 diabetes mellitus, celiac disease, systemic lupus erythematosus and systemic scleroderma in a 15-year-old girl.

Authors:  Héla Zeglaoui; Hanène Landolsi; Amani Mankai; Ibtissem Ghedira; Elyès Bouajina
Journal:  Rheumatol Int       Date:  2009-06-09       Impact factor: 2.631

2.  Systemic lupus erythematosus in the elderly.

Authors:  Achouak Achour; Amani Mankaï; Yosra Thabet; Wahiba Sakly; Fehmi Braham; Chedia Kechrid; Fethi Bahri; Elyès Bouajina; Sawssen Chouchène; Ons Haddad; Ibtissem Ghedira
Journal:  Rheumatol Int       Date:  2011-01-22       Impact factor: 2.631

3.  Clinical and serological correlates of anti-Sm autoantibodies in Chinese patients with systemic lupus erythematosus: 1,584 cases.

Authors:  Jin Dong Ni; Xi Yao; Hai Feng Pan; Xiang Pei Li; Jian Hua Xu; Dong Qing Ye
Journal:  Rheumatol Int       Date:  2009-02-05       Impact factor: 2.631

4.  [Systemic lupus and kidney disease: contribution of anti-SSA].

Authors:  Kenza Baline; Karim Zaher; Hassan Fellah; Hakima Benchikhi
Journal:  Pan Afr Med J       Date:  2015-01-14

Review 5.  Autoantibodies Associated With Connective Tissue Diseases: What Meaning for Clinicians?

Authors:  Kevin Didier; Loïs Bolko; Delphine Giusti; Segolene Toquet; Ailsa Robbins; Frank Antonicelli; Amelie Servettaz
Journal:  Front Immunol       Date:  2018-03-26       Impact factor: 7.561

6.  Serum complements and immunoglobulin profiles in systemic lupus erythematosus patients: An observational study at a teaching hospital.

Authors:  Ranjan Singh Rana; Bitan Naik; Mahima Yadav; Usha Singh; Anup Singh; Shailja Singh
Journal:  J Family Med Prim Care       Date:  2022-02-16
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.